We collect cookies for vital website function and to better serve our customers. By continuing to browse you agree to the storing of cookies on your device. See our privacy policy for details.

Vincristine (sulfate)

Item № 11764
CAS № 2068-78-2
Purity ≥95%
product image
                (CAS 2068-78-2)
     5 mg $29.00 0.00
     10 mg $55.00 0.00
     25 mg $131.00 0.00

Pricing updated 2019-06-15. Prices are subject to change without notice.

  • Kyocristine
  • Lilly 37231
  • Leurocristine
  • Novopharm
  • NSC 67574
  • Oncovin
  • VCR

Vincristine is an antimitotic vinca alkaloid, isolated from the plant V. rosea. It irreversibly blocks mitosis by binding to tubulin (Ki = 85 nM) and inhibiting tubulin polymerization.1,2 Vincristine is exported from cells via the ATP-binding cassette transporter P-glycoprotein, but not by multidrug resistance-associated protein.3 Its effectiveness in blocking the proliferation of cancer cells is affected by overexpression of P-glycoprotein.4

Recommended Products

Related Products
View Related Product Categories
Technical Information
Formal Name
22-oxo-vincaleukoblastine sulfate
CAS Number
  • Kyocristine
  • Lilly 37231
  • Leurocristine
  • Novopharm
  • NSC 67574
  • Oncovin
  • VCR
Molecular Formula
C46H56N4O10 • H2SO4
Formula Weight
A crystalline solid
221, 259, 296 nm
InChI Code
InChI Key
  • Plant/Vinca rosea

Warning - this product is not for human or veterinary use.

Shipping & Storage
Room temperature in continental US; may vary elsewhere
≥ 2 years
Downloads & Resources
Product Downloads

Download Product Insert

Download Safety Data Sheet (SDS)

Download free InChI Key generation software

Additional Information

View the Cayman Structure Database for chemical structure definitions for many Cayman products

Get Batch-Specific Data and Documents by Batch Number

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data pack, and GC-MS data.

References & Product Citations
Product Description References

1. Jordan, M.A., Himes, R.H., and Wilson, L. Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro Cancer Research 45(6), 2741-2747 (1985).

2. Towle, M.J., Salvato, K.A., Wels, B.F., et al. Eribulin induces irreversible mitotic blockade: Implications of cell-based pharmacodynamics for in vivo efficacy under intermittent dosing conditions Cancer Research 71(2), 496-505 (2011).

3. van Tellingen, O., Buckle, T., Jonker, J.W., et al. P-glycoprotein and Mrp1 collectively protect the bone marrow from vincristine-induced toxicity in vivo British Journal of Cancer 89(9), 1776-1782 (2003).

4. Chan, H.S.L., Haddad, G., Thorner, P.S., et al. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma New England Journal of Medicine 325(23), 1608-1614 (1991).

Technical Support
Contact Us
  • Toll Free Phone (USA and Canada Only): (888) 526-5351
  • Direct Phone: (734) 975-3888
Cayman Contract Services

We work with scientists to accelerate their research, drug discovery, and drug development needs through our expertise in the following areas:

Cayman Chemical

1180 East Ellsworth Road

Ann Arbor, Michigan 48108 USA

Toll Free: (800) 364-9897

(USA and Canada Only)

Fax: (734) 971-3640